Nursing

Post-Acute Care Providers Award Netsmart Top Overall Client-Rated Technology Platform for 9th Consecutive Year

OVERLAND PARK, Kan.--(BUSINESS WIRE)--#EHR--Netsmart announced it has been recognized as the top overall client-rated post-acute technology platform by Black Book…

11 months ago

Join Healthcare Leaders and Innovators at MEDITECH LIVE

The conference invites executives and clinicians to collaborate and help shape a new era in healthcare.CANTON, Mass.--(BUSINESS WIRE)--MEDITECH will be…

11 months ago

Diality Raises $28 Million to Support Continued Regulatory, Clinical and Commercial Initiatives for its User Friendly, Mobile and Connected Hemodialysis System with Category Leading Prescription Range

IRVINE, Calif.--(BUSINESS WIRE)--Diality Inc., a medical technology company developing a user friendly, mobile and connected hemodialysis system with a category…

11 months ago

interRAI Transforms Mental Health Care with Comprehensive Suite of Assessment Instruments

interRAI: Speaking one language for high quality care worldwide WATERLOO, Ontario, Aug. 09, 2023 (GLOBE NEWSWIRE) -- In a recently-published…

11 months ago

NHI Announces Second Quarter 2023 Results

MURFREESBORO, TN / ACCESSWIRE / August 8, 2023 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the…

12 months ago

NHI Announces Third Quarter 2023 Dividend

MURFREESBORO, TN / ACCESSWIRE / August 8, 2023 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay…

12 months ago

NHI Issues Investor Update

MURFREESBORO, TN / ACCESSWIRE / August 8, 2023 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor update…

12 months ago

American Psychedelic Practitioners Association and BrainFutures Publish First Professional Practice Guidelines for Psychedelic-Assisted Therapy

First-ever set of professional guidelines informed by clinical research and expert consensus will set benchmarks for practitioners in an emerging…

12 months ago

Cocrystal Pharma Selects Novel Oral Protease Inhibitor CDI-988 as Norovirus Lead

First dual coronavirus-norovirus oral antiviral is scheduled for Phase 1 in healthy volunteers In vitro studies show broad-spectrum activity against…

12 months ago

Rhythm Pharmaceuticals Announces Pre-Marketing Early Access Authorization for Setmelanotide for Use in Patients with Hypothalamic Obesity in France

-- Reimbursed early access program allows for patients with hypothalamic obesity in France to receive setmelanotide treatment ---- Early access…

12 months ago